Freeze-Drying Process Optimisation for a Small Molecule - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Freeze-Drying Process Optimisation for a Small Molecule


Pharmaceutical Technology Europe
Volume 24, Issue 6

Acknowledgments

The authors acknowledge Hiltrud Lindenblatt, PhD and senior scientist of life-cycle management CMC management at Merck KGaA, for providing the gentamicin sulphate.

Henning Gieseler* is an assistant professor and group leader in the Freeze-Drying Focus Group, Division of Pharmaceutics, University of Erlangen (Germany) and managing director of Gilyos GmbH, 15 Friedrich-Bergius-Ring, Wuerzburg, Germany, 97076, tel. +49 931 907 05678,
. Susanne Hibler is a graduate student in the Freeze-Drying Focus Group, Division of Pharmaceutics, University of Erlangen.

*To whom all correspondence should be addressed.

Submitted: 22 Mar. 2012; Accepted 23 Mar. 2012.

CITATION: When referring to this article, please cite it as "Henning Gieseler And Susanne Hibler, "Freeze-Drying Process Optimization for a Small Molecule," Pharmaceutical Technology, 36(6) (2012).

References

1. S. Rambhatla and M.J. Pikal, "Heat and Mass Transfer Issues in Freeze-drying Process Development," in Lyophilization of Biopharmaceuticals, H. R. Constantino and M.J. Pikal, Eds. (American Association of Pharmaceutical Scientists, Arlington, 1st ed., 2004), pp 75–109.

2. X. Tang and M.J. Pikal, Pharm. Res. 21 (2), 191–200 (2004).

3. M.J. Pikal and S. Shah, Int. J. Pharm. 62 (2-3), 165–186 (1990).

4. J.F. Carpenter et al., Pharm. Res. 14 (8), 969–975 (1997).

5. R.E. Johnson et al., J. Pharm. Sci. 99 (6), 2863–2873 (2010).

6. D.E. Overcashier, T.W. Patapoff, and C.C. Hsu, J. Pharm. Sci. 88 (7), 688–695 (1999).

7. J.D. Colandene et al. J. Pharm. Sci. 96 (6), 1598–1608 (2007).

8. E. Meister and H. Gieseler, J. Pharm. Sci. 98 (9), 3072–3087 (2009).

9. L.M. Her and S.L. Nail, Pharm. Res. 11 (1), 54–59 (1994).

10. J. Liu, Pharm. Dev. Technol. 11 (1), 3–28 (2006).

11. E. Meister, Methodology, Data Interpretation and Practical Transfer of Freeze-Dry Microscopy, PhD. Thesis, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen (2009).

12. F. Fonseca et al., Biotechnol. Prog. 20 (1), 229–238 (2004).

13. M.J. Pikal, J. Parenter. Sci. Technol. 39 (3), 115–139 (1985).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here